Cargando…
Identification of phosphoenolpyruvate carboxykinase 1 as a potential therapeutic target for pancreatic cancer
Pancreatic cancer is the third leading cause of cancer-related mortalities and is characterized by rapid disease progression. Identification of novel therapeutic targets for this devastating disease is important. Phosphoenolpyruvate carboxykinase 1 (PCK1) is the rate-limiting enzyme of gluconeogenes...
Autores principales: | Zhu, Xiao-ren, Peng, Shi-qing, Wang, Le, Chen, Xiao-yu, Feng, Chun-xia, Liu, Yuan-yuan, Chen, Min-bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497628/ https://www.ncbi.nlm.nih.gov/pubmed/34620839 http://dx.doi.org/10.1038/s41419-021-04201-w |
Ejemplares similares
-
Phosphoenolpyruvate carboxykinases as emerging targets in cancer therapy
por: Yu, Yong, et al.
Publicado: (2023) -
The requirement of phosphoenolpyruvate carboxykinase 1 for angiogenesis in vitro and in vivo
por: Yao, Jin, et al.
Publicado: (2022) -
Kinetic and functional properties of human mitochondrial phosphoenolpyruvate carboxykinase
por: Escós, Miriam, et al.
Publicado: (2016) -
Neddylation of phosphoenolpyruvate carboxykinase 1 controls glucose metabolism
por: Gonzalez-Rellan, María J., et al.
Publicado: (2023) -
Phosphoenolpyruvate Cycling via Mitochondrial Phosphoenolpyruvate Carboxykinase Links Anaplerosis and Mitochondrial GTP with Insulin Secretion
por: Stark, Romana, et al.
Publicado: (2009)